Humana (HUM) Expected to Announce Quarterly Earnings on Tuesday

Humana (NYSE:HUM) is anticipated to post its quarterly earnings results before the market opens on Tuesday, February 11th. Analysts expect Humana to post earnings of ($2.26) per share and revenue of $28.84 billion for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Humana Trading Down 0.1 %

Shares of Humana stock opened at $292.82 on Tuesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a 50-day moving average of $275.36 and a 200-day moving average of $301.04. Humana has a 52-week low of $213.31 and a 52-week high of $406.46. The stock has a market cap of $35.26 billion, a PE ratio of 25.94, a PEG ratio of 2.21 and a beta of 0.56.

Wall Street Analyst Weigh In

HUM has been the topic of a number of analyst reports. Royal Bank of Canada reduced their price target on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Morgan Stanley increased their target price on Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Piper Sandler boosted their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a report on Tuesday, October 8th. Finally, TD Cowen boosted their target price on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Nineteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $297.68.

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.29% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.